Oct 14, 2024 | Kurt Harden, MedBen Rx News, Pharmacogenomics, Precision medicine
On October 1, MedBen Chairman and CEO Kurt Harden spoke on the topic “A Third-Party Payer’s Approach to Providing Quality Care While Minimizing Cost” at the 2024 Ventegra Client Conference. Ventegra serves as MedBen Rx’s pharmacy benefits partner....
Oct 1, 2024 | Genomics, Kurt Harden, News, Nutrigenomics, Pharmacies, Pharmacogenomics, Wellness
MedBen Chairman & CEO Kurt Harden and Profero Team Director of Precision Medicine Cynthia Yu were featured presenters at the 11th Annual Sherrill-Morgan Healthcare Innovation Conference on September 18th. Harden and Yu spoke on the topic of genomic testing — what...
May 29, 2024 | Announcements, Caroline Fraker, Doug Freeman, Kurt Harden, MedBen Board of Directors\, MedBen employees
At the recent Annual Meeting for MedBen, Doug Freeman, who for over 36 years served as President and later Chairman of Medical Benefits Mutual Life Insurance Co. (MedBen), retired from the Board of Directors. At the same meeting, Kurt Harden, previously MedBen’s...
May 13, 2024 | Diabetes, Kurt Harden, MedBen University, Mounjaro, Ozempic, Wegovy, Weight loss, Zepbound
At recent MedBen University roundtables, MedBen President & CEO Kurt Harden examined how the growing public awareness of two diabetes drugs with a desirable side effect – significant weight loss – means that these $1,000-per-month medications are not always being...
